United Kingdom

People: Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

23 Aug 2019
Change (% chg)

$-0.00 (-0.00%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Esfandiari, Javan 

Mr. Javan Esfandiari is Chief Science and Technology Officer of the Company. rior to joining the company, Mr. Esfandiari co-founded Sinovus Biotech AB, a Swedish biotech company where he served as Director of R&D until Chembio acquired Sinovus. He previously served as Director of R&D for On-Site Biotech. Mr. Esfandiari is the inventor of Chembio’s patented Dual Path Platform (DPP®) technology and developed more than 30 rapid point-of-care diagnostic products in the human and veterinary fields. Mr. Esfandiari received a B.S. in Clinical Chemistry and studied to M. Sc. Level in Molecular Biology from Lund University, Sweden.

Basic Compensation

Total Annual Compensation, USD 405,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 9,825
Fiscal Year Total, USD 414,825

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --